← Browse by Condition
Medical Condition
septic cardiomyopathy
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 4
ClinicalMetric tracks all active clinical trials for septic cardiomyopathy sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 4 1
Top Sponsors
1 trial
1 trial
Recruiting Clinical Trials
NCT05184296
Recruiting
ExtraCorporeal Membrane Oxygenation in the Therapy for REfractory Septic Shock With Cardiac Function Under Estimated
Enrollment
64 pts
Location
China
Sponsor
Second Affiliated Hospital of ...
NCT06898723 Phase 4
Recruiting
The Preventive Effect of Shenfu Injection on Myocardial Dysfunction in Sepsis
Enrollment
440 pts
Location
China
Sponsor
First Affiliated Hospital of W...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology